Skip to main content
Field note 04 / Inherited conditions

Carrier screening.
Understand the question.

Carrier screening can inform a conversation about inherited conditions. Understanding the purpose and reach of the test is essential to understanding the result.

01

What carrier testing looks for

For many recessive conditions, a person can carry one disease-associated gene change while two copies are needed for the condition to occur. Carrier testing looks for such changes. Testing both prospective parents can help inform a couple’s chance of having a child with a particular condition. MedlinePlus describes the uses of carrier testing.

The question is specific to the condition, inheritance pattern and test. A general wellness result or an ancestry report should not be assumed to answer it.

02

The scope of a test matters

Consumer tests do not all examine the same variants, so their reports can differ. A report needs to be read with the test’s intended use and limitations in mind. The FDA explains these differences.

Ask what was examined.

“No finding reported” is incomplete without knowing which genes, variants and types of changes the assay could assess. Ask the laboratory to explain that scope.

A DNA file accepted by software is not, by itself, evidence that it can support a carrier-screening conclusion. Format compatibility and clinical suitability need separate consideration.

03

Prepare for the professional conversation

Genetic information can have emotional and family implications. A genetics professional can help explain a particular test’s benefits, risks and limits before you decide how to proceed. Read the National Library of Medicine’s overview.

  • What question is this test intended to answer?
  • Which conditions and types of genetic change are included?
  • How should my family history inform the testing plan?
  • Would partner testing or another test be appropriate?
  • Who can help interpret an uncertain or unexpected result?

This is general educational information, not a personal reproductive-risk assessment or an offer of a validated Atlagene carrier-screening service.

Continue with result language

Read the sources

MedlinePlus: Uses of genetic testingFDA: Direct-to-consumer test limitationsMedlinePlus: Genetic testing risks and limitations

Published 8 September 2026. Written by the Atlagene team.

All field notes
Carrier screening explained | Atlagene